CAR-T cells and bispecific antibodies have advanced our therapeutic armamentarium for haematological malignancies. The programme of the ESH 2nd How I Manage "CAR-T Therapies and Bispecific Antibodies for my patients"" conference aims to provide an overview of the benefits and risks of currently available therapies for acute lymphoblastic leukaemia, lymphoma and multiple myeloma. Special focus will be placed on the advantages and disadvantages of bispecific antibodies vs. cellular therapies (including T cells, NK cells and transplant strategies). Future perspectives regarding applications in other haematological malignancies and in solid tumours will also be discussed. Chairs: Ulrich Jäger, Marie José Kersten, Loretta Nastoupil

Date: Friday 29 September - Sunday 1 October 2023
Venue: Vienna House Andels' Berlin, Germany

CAR-T cells and bispecific antibodies have advanced our therapeutic armamentarium for haematological malignancies. The programme of this ESH conference aims to provide an overview of the benefits and risks of currently available therapies for acute lymphoblastic leukaemia, lymphoma and multiple myeloma. Special focus will be placed on the advantages and disadvantages of bispecific antibodies vs. cellular therapies (including T cells, NK cells and transplant strategies). Future perspectives regarding applications in other haematological malignancies and in solid tumours will also be discussed.

The format of the meeting is based on the analysis and discussion of clinical case studies. It will adopt a problem-solving approach, addressing practical considerations and guidelines. Emphasis will be placed on open discussion, including a maximum level of interaction between faculty and registered participants. In addition to the scientific and medical issues addressed during the conference, the questions of affordability of and access to these novel expensive treatments will be tackled by medical experts, representatives of patient organisations, economists, authorities and industry.

Continuing Medical Education (CME) credit points will be awarded to physicians for the time they will spend at the meeting improving their knowledge and skills. ESH is a provider of the European Haematology CME system.

Posters and Brief Oral Communications:

Registered participants are invited to submit their clinical cases and abstracts abstracts. Selected clinical cases and abstracts will be presented as brief oral communications or posters.

Call for abstracts and clinical cases: deadline 2 July 2023

The meeting will be of interest to:

  • Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
  • Junior scientists and clinicians (MD, PhD)
  • PhD candidates and clinical residents still in-training

Learning Objectives:

Upon completion of this CME activity, participants should be able to:

  • Understanding of the current landscape of bispecific antibodies
  • Understanding of the current landscape of CAR-T cells
  • Novel approaches and technologies in the field
  • Integration of novel therapies into current clinical practice
  • Future perspectives in bispecific antibody and cellular therapies in haematological malignancies and solid tumours Scientific

Topics:

  • Diffuse large B-cell Lymphoma: How to optimize the benefit of CAR T-cell therapy?
  • Diffuse large B-cell lymphoma: How to minimize potential risks of CAR T-cell therapy?
  • Multiple Myeloma: targeting BCMA with bispecifics and CARs
  • Bispecific antibodies in the treatment of B-NHL
  • Acute lymphoblastic leukaemia (ALL): the role of CARs and Bispecifics
  • Lessons from paediatric haematology
  • Perspectives: CARs and bispecifics for haematological malignancies

The programme will include:

  • Keynote Lecture
  • Plenary Sessions
  • Meet the Expert Sessions
  • Roundtables
  • Debates
  • Mentored Poster Walks
  • Brief Oral Communications
  • Voting technology

Conference website and registration

External Events

Jan 24
23
24
31
Feb 24
6
7
17
Mar 24
1
8
23
Apr 24
12
22
Oct 24
28
January 23rd 2024
Post ASH Significant Highlights (3)
This meeting will provide an overview of the most innovative scientific and clinical data presented at ASH 2023 that...
Details
January 24th 2024
BSHT Annual Scientific Meeting (1)
Join scientists, clinicians, researchers, laboratory staff and all those interested in learning more about thrombosis...
Details
January 31st 2024
Post ASH Highlights for Scotland - What's New i...
This meeting will provide an overview of the most innovative scientific and clinical data presented at ASH 2023 that...
Details
February 6th 2024
Post ISTH & ASH Headlines 2024
This national non-malignant haematology evidence update meeting will include sessions covering relevant topics in thr...
Details
February 7th 2024
UK Haemato-Oncology Clinical Studies Group Tria...
UK Haemato-Oncology Clinical Studies Group Trials Update meeting suitable for anyone working in this field.
Details
February 17th 2024
FRCPath 1 Haematology Revision Course (3)
This is a popular two-day intensive exam-oriented course targeted towards haematology trainees aiming to sit their FR...
Details
March 1st 2024
FRCPath Haemostasis and Thrombosis Training and...
The course is suitable for SpRs preparing for the part 2 FRCPath examination but is also suitable for clinicians, sci...
Details
March 8th 2024
ESH 3rd Translational Research Conference: Chro...
ESH Translational Research Conferences propose programmes of leading-edge basic and clinical science, as well as oppo...
Details
March 23rd 2024
Spring 2024 UCLH FRCPath Part 2 Revision Course
Intensive two-day course held at UCLH on a Saturday and Sunday to prepare candidates about to sit the Part 2 FRCPath...
Details
April 12th 2024
ESH 9th Translational Research Conference: Myel...
TheESH 9th Ttranslational Research Conference on MDS proposes a programme of leading-edge basic and clinical science,...
Details
April 22nd 2024
BGS Transfusion
BGS Transfusion is a three-day symposium aimed at all levels of staff working in blood transfusion.
Details
October 28th 2024
3rd European Congress on Hematology and Blood D...
Hematology beyond blood: A holistic approach
Details